查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466005

表觀遺傳學市場：按產品、技術、工藝、應用和最終用戶分類 - 全球預測 2024-2030

Epigenetics Market by Product, Technique, Methods, Application, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年表觀遺傳學市場規模為37.1億美元，預計2024年將達41億美元，2030年將達76.3億美元，複合年成長率為10.82%。

表觀遺傳學是指對不涉及 DNA 序列變化的可遺傳表現型修飾的分析。我們可以在不改變基本遺傳密碼的情況下檢查 DNA 和組蛋白中發生的化學修飾並影響基因表現。這些表觀遺傳變化可能受到年齡、環境和疾病狀態等多種因素的影響，並作為可逆機制傳遞給下一代。表觀遺傳學為基因表現的控制增加了一層複雜性，對於我們對遺傳學、發育和遺傳的理解具有重要意義。表觀遺傳學的應用範圍從生物醫學研究到治療性介入。在研究中，表觀遺傳學提供了對發育生物學和疾病發病機制的深入了解。在臨床方面，它可用於癌症治療、代謝紊亂和個人化醫療。典型的最終用戶包括學術和研究機構、製藥和生物技術公司以及診斷中心。由於全球慢性病和遺傳患者病率的顯著增加、政府在藥物發現和開發方面的積極努力和投資以及對個人化醫療的日益關注，對錶觀遺傳學的需求正在增加。然而，表觀遺傳學技術的新興市場面臨著開發成本高、認知度低、表觀遺傳學適用範圍窄等挑戰，這些都阻礙了表觀遺傳學的普及。持續研究和開發表觀遺傳學的進展以及擴大表觀遺傳學在癌症以外領域的應用表明表觀遺傳學進步的潛在機會。

主要市場統計
基準年[2023] 37.1億美元
預測年份 [2024] 41億美元
預測年份 [2030] 76.3億美元
複合年成長率（%） 10.82%

增加產品表觀遺傳學研究中試劑與套件的使用

酵素在表觀遺傳學研究中發揮著極其重要的作用，因為它們負責付加和去除表觀遺傳標記，例如 DNA 和組蛋白上的甲基。 DNA 修飾酶，例如DNA甲基轉移酵素(DNMT) 和 TET 酶，是表觀遺傳修飾的重要工具，廣泛用於研究 DNA 甲基化和羥甲基化模式。蛋白質修飾酶，例如組蛋白乙醯轉移酶 (HAT)、去乙醯化酶 (HDAC)、甲基轉移酵素和去甲基酶，可改變組蛋白並影響染色質結構和基因表現。表觀遺傳研究所需的工具，例如 DNA 定序儀、PCR 放大器、用於染色質剪切的超音波儀和先進的成像系統，是闡明表觀遺傳修飾的基礎。這些儀器與微孔盤、移液管和軟體等重要配件結合，有助於對表觀遺傳現象進行精確分析。專為表觀遺傳學研究量身定做的試劑和套件，例如亞硫酸氫鹽轉化套件和染色質免疫沉澱套件，可以幫助簡化和標準化流程。 5-hmC 和 5-mC 分析套件簡化了 DNA 甲基化和羥甲基化的檢測和定量。針對甲基化胞嘧啶和各種組蛋白修飾等表觀遺傳標記的有效抗體對於西方印漬術、螢光和染色質免疫沉澱 (ChIP) 等技術至關重要。亞硫酸氫鹽轉換試劑套件將未甲基化的胞嘧啶殘基轉換為尿嘧啶，因此可以透過定序或 PCR 區分甲基化和未甲基化的 DNA，是 DNA 甲基化研究的基本方法。 ChIP-seq套件簡化了染色質免疫沉澱和定序的過程。未修飾和轉譯後修飾的核心組蛋白及其變體可用於染色質重塑的體外研究以及了解特定修飾如何影響基因表現。全基因組擴增試劑套件有助於將納克量的 DNA 擴增至微克水平，並且在起始材料有限時（例如在單細胞研究中）對於表觀遺傳分析至關重要。表觀遺傳學服務包括 DNA 甲基化分析、組蛋白修飾圖譜和染色質可及性測定。這些專業服務利用亞硫酸氫鹽測序等經典技術和下一代測序等現代高通量方法來支持研究人員獲取和解釋表觀遺傳資料。表觀遺傳學研究產生大量資料集，需要先進的生物資訊工具進行分析。軟體解決方案提供資料處理、視覺化和整合平台，能夠破解複雜的表觀遺傳網路。缺乏內部能力或尋求高度專業專業知識的研究機構越來越青睞服務。相反，軟體起著補充作用，隨著資料量和複雜性的增加，軟體變得越來越重要。

技術 擴大次世代定序儀在全基因組甲基化分析的應用

質譜分析是一種估計離子質荷比的分析技術。它用於表觀遺傳學研究，分析 DNA 和組蛋白的變化，例如甲基化和乙醯化。這種方法非常準確，甚至可以檢測表觀遺傳標記的微小變化。當需要高特異性和靈敏度或處理複雜混合物時，研究人員可能更喜歡質譜分析。次世代定序(NGS) 是一種強大的技術，可以對 DNA 和 RNA 進行高通量定序，對於了解整個基因組的遺傳和表觀遺傳模式至關重要。 NGS 可用於表觀遺傳學應用，例如全基因組甲基化分析、染色質免疫沉澱定序 (ChIP-seq) 和 RNA 定序 (RNA-seq)，以研究轉錄水平的表觀遺傳學變化。當需要全面的全基因組分析或研究表觀遺傳學變化對基因表現的影響時，NGS 是首選。定量聚合酵素鏈鎖反應(qPCR) 和聚合酵素鏈鎖反應(PCR) 是用於擴增和定量特定 DNA 序列的技術。在表觀遺傳學中，這些方法可以量化特定基因的甲基化狀態並測量由於表觀遺傳修飾而導致的基因表現的變化。 PCR 和 qPCR 供對特定 DNA 或 RNA 片段進行靶向分析而不是廣泛的高通量方法感興趣的研究人員使用。超音波處理是一種物理剪切過程，利用聲能將核酸和蛋白質分解成更小的碎片。它通常在樣品製備過程中用於表觀遺傳學，例如 ChIP-seq 方法，其中在進行免疫沉澱之前需要剪切染色質。當需要均勻剪切 DNA 時，尤其是在準備定序研究時，應選擇超音波處理。此外，在選擇這些表觀遺傳分析技術時，研究人員會考慮樣本的性質、所需的解析度以及所需資料的特異性和廣度。質譜分析具有高度特異性，非常適合檢測新的或微小的變化。 NGS 為全基因組分析提供全面、高通量的功能。

方法增加 X 染色體惰性中 DNA 甲基化的利用

DNA 甲基化是一種表觀遺傳修飾技術，當位於基因啟動子時，會導致基因表現的抑制。它在多種生物過程中發揮重要作用，包括胚胎發育、X染色體惰性和重複元件的抑制。在研究早期發育階段以及涉及印記和 X 染色體惰性的疾病時，首選 DNA 甲基化分析。分析 DNA 甲基化模式的技術包括亞硫酸氫定序、甲基化特異性PCR (MSP) 和基於陣列的方法。組蛋白修飾發生在 DNA 包裹的組蛋白上。組蛋白上各種胺基酸的化學基團（如甲基、乙醯基、磷酸鹽和泛素）的付加或減少會影響染色質結構和基因活性。例如，乙醯化通常與轉錄活化相關，而甲基化可以活化或抑制基因表現，這取決於特定的胺基酸和付加的甲基的數量。染色質免疫沉澱分析法(ChIP)、隨後的核苷酸定序(ChIP-seq)、基於質譜的方法和各種組蛋白修飾可用於研究基因調控、染色質動力學和對環境刺激的轉錄反應。修飾的研究是有利的，因為它。 DNA 甲基化和組蛋白修飾對於理解驅動基因表現的複雜調控網路至關重要。 DNA 甲基化分析對於穩定、長期的基因靜默很重要的情況至關重要，例如發育生物學和疾病研究。相反，組蛋白修飾分析提供了染色質和轉錄變化的動態視圖。它對於研究基因表現的快速變化以及環境因素對染色質結構的影響特別有用。

表觀遺傳學工具在應用腫瘤學的應用不斷增加

由於全球與心臟相關的健康問題日益普遍，心血管疾病（CVD）已成為表觀遺傳學研究的主要焦點。表觀遺傳工具，包括 DNA 甲基化、組蛋白修飾和非編碼 RNA 表達，被認為會影響 CVD 的發病和進展。旨在了解這些修飾的研究可能會導致識別潛在的生物標記物，用於早期檢測和標靶治療。發育生物學是表觀遺傳學研究的重要應用，揭示表觀遺傳學變化如何控制從胚胎發育到成年的發育過程。該領域的研究人員對發育過程中表觀遺傳譜如何變化以及這些變化如何導致發育障礙特別感興趣。在免疫學中，表觀遺傳學應用於了解免疫反應的調節以及治療自體免疫疾病、過敏和發炎的潛力。該應用領域在很大程度上依賴於對錶觀遺傳過程和免疫細胞分化之間相互作用的理解。這種需求是由對新療法的需求所驅動的，治療方法可以改變免疫系統的行為，而不會產生與現有治療方法相關的副作用。代謝疾病的表觀遺傳學研究針對肥胖、糖尿病和其他代謝症候群等疾病。表觀遺傳學用於破解導致這些疾病的基因與環境的相互作用。該領域為旨在重置代謝特徵的生物標記發現和表觀遺傳藥物開發提供了一個富有成效的領域。鑑於表觀遺傳學修飾在癌症發展中的作用，腫瘤學是表觀遺傳學最突出的應用領域。針對 DNA 甲基化和組蛋白修飾酶的表觀遺傳藥物已投入使用，並正在針對各種類型的癌症進行廣泛研究。由於對精準醫療的需求和全球癌症的高負擔，對錶觀遺傳學腫瘤學方法的需求是巨大的。腫瘤學是一個突出的領域，由於癌症相關死亡的影響很大，因此獲得了大量投資和研究。因此，各種表觀遺傳藥物正在穩步獲得核准，形成了強大的治療管道。

最終用戶：學術和研究機構對錶觀遺傳學工具的需求不斷成長

學術和研究機構已成為表觀遺傳學基礎研究和發現的主要場所。這些機構對先進的研究工具有強烈的需求，例如次世代定序儀（NGS）、生物資訊平台以及表觀遺傳學套件和試劑。這裡的重點是了解表觀遺傳變化的機制和影響，而不是直接的商業性應用。委外研發機構(CRO) 充當各種生物技術、製藥和醫療設備公司的第三方服務供應商。我們提供各種服務，從早期研究到臨床試驗和上市後支援。在表觀遺傳學方面，CRO 需要最尖端科技，為藥物發現和開發計劃提供高通量能力和可靠的檢驗服務。 CRO 喜歡符合製藥業嚴格監管標準的穩健、可擴展的解決方案。參與新藥和治療方法開發和商業化的製藥和生物技術公司越來越受到表觀遺傳學見解的影響。這些公司需要一個全面的表觀遺傳學平台來簡化藥物發現、生物標記開發和治療監測。製藥和生物技術公司更喜歡能夠加快上市速度、功效和安全性的整合解決方案。

區域洞察

北美表觀遺傳學市場主要由美國推動，原因是美國在研發方面的大量投資、製藥和生物技術公司的強大實力以及癌症等慢性疾病的高發病率。在南美洲，表觀遺傳學的採用仍處於早期階段，由於遺傳疾病和癌症的盛行率不斷增加，表觀遺傳學的應用具有發展的潛力。巴西支持表觀遺傳學的發展，因為其醫療保健部門不斷發展，公眾對先進治療的認知不斷提高。在中國、日本和印度等新興經濟體的推動下，亞太地區表觀遺傳學領域正經歷快速轉型。中國的專利申請迅速增加，顯示政府和私人對錶觀遺傳學的強烈興趣。日本政府正在鼓勵精準醫療，從而增加了表觀遺傳學研究計畫的資金。印度對表觀遺傳學研究的參與不斷增加，合作和研究的數量也不斷增加。歐洲表觀遺傳學市場強勁，以德國、英國和法國等國為首。廣泛的研究活動、完善的醫療保健系統以及私營和公共部門不斷成長的投資正在推動該地區的發展。此外，主要企業和學術機構之間的積極合作支持先進表觀遺傳療法的開發。在中東地區，由於癌症等疾病盛行率的上升和醫療基礎設施的擴張，表觀遺傳學正在逐漸發展。對個人化醫療的興趣正在穩步成長並影響購買模式。在非洲，表觀遺傳學的發展仍處於早期階段，研究設施有限。然而，由於醫療保健研究領域國際合作的增加，該領域仍有擴張的潛力。

FPNV定位矩陣

FPNV定位矩陣對於評估表觀遺傳學市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對錶觀遺傳學市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.表觀遺傳學市場的市場規模和預測是多少？

2.表觀遺傳學市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3.表觀遺傳學市場的技術趨勢和法規結構是什麼？

4.表觀遺傳學市場主要廠商的市場佔有率是多少？

5. 進入表觀遺傳學市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地慢性病和遺傳疾病的盛行率正在顯著增加。
      • 政府對藥物發現和開發的有利措施和投資
      • 個人化醫療的趨勢日益成長
    • 抑制因素
      • 表觀遺傳學技術開發成本高
    • 機會
      • 持續進行表觀遺傳學的研究與發展活動
      • 將表觀遺傳學的應用擴展到非腫瘤學領域
    • 任務
      • 表觀遺傳學缺乏認知且應用有限
  • 市場區隔分析
    • 產品：增加表觀遺傳學研究試劑和套件的使用
    • 技術：擴大次世代定序在全基因組甲基化分析的應用
    • 方法：增加 X 染色體惰性中 DNA 甲基化的利用率
    • 應用：增加表觀遺傳學工具在腫瘤學的應用
    • 最終用戶：學術和研究機構對錶觀遺傳學工具的需求不斷成長
  • 市場趨勢分析
    • 一家大公司進入美洲地區，正在進行旨在臨床和農業應用以及技術進步的表觀遺傳學研究。
    • 隨著人口老化的加劇，亞太地區的研發活動不斷增加。
    • 歐洲、中東和非洲地區先進的醫療保健基礎設施和與環境和農業應用相關的強大表觀遺傳學研究活動
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章表觀遺傳學市場：依產品

  • 酵素
  • 樂器及配件
  • 試劑和套件
  • 服務
  • 軟體

第7章表觀遺傳學市場：依技術分類

  • 質譜
  • 次世代定序
  • 聚合酵素鏈鎖反應與定量聚合酵素鏈鎖反應
  • 超音波

第 8 章表觀遺傳學市場（依方法）

  • DNA甲基化
  • 組蛋白修飾

第9章表觀遺傳學市場：依應用分類

  • 心血管疾病
  • 發育生物學
  • 免疫學
  • 代謝性疾病
  • 腫瘤學

第 10 章表觀遺傳學市場：依最終使用者分類

  • 學術研究所
  • 合約調查機構
  • 製藥和生物技術公司

第11章美洲表觀遺傳學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區表觀遺傳學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的表觀遺傳學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Zenith 和 Sencora 合作加速 ZEN-3694 項目
    • FOXO 與 DataRobot 合作進行以人工智慧為基礎的表觀遺傳生物標記研究
    • Zymo Research 和 Opentrons 合作實現新型無細胞 DNA 分離化學的自動化
    • MSU 生物化學家獲得 NIH 280 萬美元津貼，用於研究泛自閉症障礙的表觀遺傳學
    • 安捷倫宣布收​​購用於癌症研究的高性能 NGS靶向序列捕獲工作流程開發商 Avida Biomed
    • Astra Zeneca推進產品線，在 AACR 上強調免疫腫瘤學、ADC、細胞治療和表觀遺傳學的進展
    • Biomodal 發布遺傳學和表觀遺傳學解決方案
    • Chroma Medicine 專注於表觀遺傳編輯
    • 易卜生收購 Epizyme 以擴大腫瘤產品組合
    • Zenith Epi Genetics 宣布開始由美國國家癌症研究所 (NCI) 贊助的多項腫瘤學臨床試驗

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-0D217D5ADE3D

[190 Pages Report] The Epigenetics Market size was estimated at USD 3.71 billion in 2023 and expected to reach USD 4.10 billion in 2024, at a CAGR 10.82% to reach USD 7.63 billion by 2030.

Epigenetics refers to the analysis of heritable phenotype modifications that do not involve alterations in the DNA sequence. It examines the chemical modifications that occur on DNA and histone proteins, which can affect gene expression without changing the underlying genetic code. These epigenetic changes can be influenced by several factors, including age, environment, and disease state, and they are reversible mechanisms passed down to subsequent generations. Epigenetics provides an additional layer of complexity to the regulation of gene expression, and it has significant implications for our understanding of genetics, development, and inheritance. Applications of epigenetics span from biomedical research to therapeutic interventions. In research, epigenetics offers insights into developmental biology and the etiology of diseases. Clinically, it has implications in cancer treatment, metabolic disorders, and personalized medicine. The primary end-users include academic & research institutes, pharmaceutical & biotech companies, and diagnostic centers. The need for epigenetics is increasing due to substantial growth in the prevalence of chronic and genetic disorders worldwide, favorable governmental initiatives and investments in drug discovery and development, and a growing inclination toward personalized medicines. However, the market faces certain challenges, including the high cost of developing epigenetics technologies, lack of awareness, and limited application of epigenetics, hindering the adoption of epigenetics. Ongoing research and development activities for the advancement of epigenetics and expanding the application of epigenetics in non-oncology fields present potential opportunities for the development of epigenetics.

KEY MARKET STATISTICS
Base Year [2023] USD 3.71 billion
Estimated Year [2024] USD 4.10 billion
Forecast Year [2030] USD 7.63 billion
CAGR (%) 10.82%

Product: Increasing usage of reagents & kits for epigenetic research

Enzymes play a pivotal role in epigenetic research, as they are responsible for adding or removing epigenetic markers such as methyl groups on DNA or histones. DNA-modifying enzymes, such as DNA methyltransferases (DNMTs) and TET enzymes, are crucial tools in epigenetic modification, widely used in research to study DNA methylation and hydroxymethylation patterns. Protein-modifying enzymes such as histone acetyltransferases (HATs), deacetylases (HDACs), methyltransferases, and demethylases alter histone proteins, influencing chromatin structure and gene expression. The tools necessary for epigenetic research, such as DNA sequencers, PCR amplifiers, sonicators for chromatin shearing, and advanced imaging systems, are fundamental to elucidating epigenetic modifications. These instruments, paired with essential accessories such as microplates, pipettes, and software, facilitate the precise analysis of epigenetic phenomena. Reagents and kits tailored for epigenetic research, which include bisulfite conversion kits or chromatin immunoprecipitation kits, serve to streamline and standardize processes. 5-hmC & 5-mC analysis kits simplify detecting and quantifying DNA methylation and hydroxymethylation. Validated antibodies against epigenetic markers such as methylated cytosine or various histone modifications are indispensable for techniques such as western blotting, immunofluorescence, and chromatin immunoprecipitation (ChIP). Bisulfite conversion kits convert unmethylated cytosine residues to uracil, which enables the discrimination of methylated from unmethylated DNA via sequencing or PCR, serving as a cornerstone method in DNA methylation studies. ChIP-seq kits streamline the process of performing chromatin immunoprecipitation followed by sequencing. Unmodified and post-translationally modified core histone proteins and their variants are utilized for in vitro studies of chromatin remodeling and to understand how specific modifications influence gene expression. Whole genome amplification kits facilitate the amplification of nanogram quantities of DNA to microgram levels, which is essential for epigenetic analysis when starting material is limited, such as in single-cell studies. Epigenetics services include DNA methylation profiling, histone modification mapping, and chromatin accessibility assays. These specialized services leverage classic techniques, such as bisulfite sequencing, and modern high-throughput methods, such as next-generation sequencing, to support researchers in epigenetic data acquisition and interpretation. Epigenetics research yields large datasets that necessitate sophisticated bioinformatics tools for analysis. Software solutions provide data processing, visualization, and integration platforms, enabling the decoding of complex epigenetic networks. Services are increasingly becoming preferred for research entities lacking in-house capabilities or those looking for highly specialized expertise. Conversely, the software serves a complementary role, growing in importance as the volume and complexity of data escalate.

Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling

Mass spectrometry is an analytical method that estimates the mass-to-charge ratio of ions. It is used in epigenetic studies to analyze DNA and histone changes, such as methylation and acetylation. The method is very precise, allowing for the detection of even small changes in epigenetic marks. Researchers may prefer mass spectrometry when they require high specificity and sensitivity or deal with complex mixtures. Next-generation sequencing (NGS) is a powerful method that allows for high-throughput sequencing of DNA and RNA, which is critical for understanding genetic and epigenetic patterns across the genome. NGS can be used for epigenetic applications such as genome-wide methylation profiling, chromatin immunoprecipitation sequencing (ChIP-seq), and RNA sequencing (RNA-seq) to study epigenetic changes at the transcriptional level. NGS is preferred when comprehensive, genome-wide analysis is required or while examining the effects of epigenetic changes on gene expression. Quantitative polymerase chain reaction (qPCR)and polymerase chain reaction (PCR) are techniques used to amplify and quantify specific DNA sequences. In epigenetics, these methods can quantify the methylation status of particular genes or measure gene expression changes resulting from epigenetic modification. PCR and qPCR are used by researchers that are interested in targeted analysis of specific DNA or RNA fragments rather than a broad, high-throughput approach. Sonication is a physical shearing process that uses sound energy to break nucleic acids and proteins into smaller fragments. It is often used in epigenetics during the preparation of samples for methods such as ChIP-seq, where chromatin must be sheared before immunoprecipitation can occur. Sonication is selected when uniform shearing of DNA is necessary, particularly in preparation for sequencing studies. Moreover, when choosing among these epigenetic analysis techniques, researchers consider the nature of their sample, the resolution needed, and the specificity and breadth of data they require. Mass spectrometry offers high specificity, making it ideal for detecting novel or small changes. NGS presents comprehensive and high-throughput capabilities for whole-genome analysis.

Methods: Rising utilization of DNA methylation for X-chromosome inactivation

DNA methylation is an epigenetic modification technique that leads to the repression of gene expression when located in gene promoters. It plays a critical role in diverse biological processes such as embryonic development, X-chromosome inactivation, and suppression of repetitive elements. DNA methylation analysis is preferred when studying early developmental stages and diseases that involve imprinting or X-chromosome inactivation. Techniques utilized for analyzing DNA methylation patterns include bisulfite sequencing, methylation-specific PCR (MSP), and array-based methods. Histone modifications occur on the histone proteins around which DNA is wound. The addition or reduction of chemical groups such as methyl, acetyl, phosphate, and ubiquitin to various amino acids on histones can affect chromatin structure and gene activity. Acetylation, for instance, is generally associated with transcriptional activation, while methylation can activate or suppress gene expression, relying on the specific amino acid and the number of methyl groups added. Research in gene regulation, chromatin dynamics, and transcriptional response to environmental stimuli can favor histone modification studies as it includes chromatin immunoprecipitation (ChIP) followed by sequencing (ChIP-seq), mass spectrometry-based methods and specific antibodies that recognize various histone modifications. DNA methylation and histone modifications are paramount for understanding the complex regulatory networks that drive gene expression. DNA methylation analyses are indispensable in certain contexts, such as developmental biology and disease studies where stable, long-term gene silencing is crucial. In contrast, histone modification analyses offer a dynamic view of chromatin and transcriptional changes. They are particularly beneficial for investigating rapid gene expression changes and the effects of environmental factors on chromatin structure.

Application: Increasing application of epigenetic tools in oncology

Cardiovascular diseases (CVDs) are a major area of focus for epigenetic research due to the increasing prevalence of heart-related health issues globally. Epigenetic tools, including DNA methylation, histone modification, and non-coding RNA expression, are believed to influence the development and progression of CVDs. Studies aimed at understanding these modifications could lead to identifying potential biomarkers for early detection and targeted therapies. Developmental biology is a critical application for epigenetic research, illuminating how epigenetic changes govern development processes from embryogenesis to adulthood. Researchers in this field are particularly interested in the way epigenetic profiles change during development, and they can result in developmental disorders when altered. In immunology, epigenetics applies to understanding the regulation of immune response and the potential to treat autoimmune diseases, allergies, and inflammatory conditions. The application segment relies heavily on understanding the interaction between epigenetic processes and immune cell differentiation. The need is propelled by the need for new therapeutic methods that modify immune system behavior without the adverse effects associated with current treatments. Epigenetic research in metabolic diseases targets conditions such as obesity, diabetes, and other metabolic syndromes. Epigenetics is used to decipher the gene-environment interactions contributing to such diseases. This arena provides fruitful ground for biomarker discovery and epigenetic drug development aimed at resetting metabolic profiles. Oncology is the most prominent application of epigenetics, given the role of epigenetic modifications in cancer development. Epigenetic drugs targeting DNA methylation and histone modification enzymes are already in use and are being studied extensively for various types of cancers. The need for epigenetic oncology approaches is immense, driven by the need for precision medicine and the high burden of cancer worldwide. Oncology, as a prominent segment, has witnessed significant investment and research due to the high impact of cancer-related deaths. It has steadily resulted in various approved epigenetic drugs and a robust pipeline of therapies.

End-User: Growing need for epigenetic tools from academic & research institutes

Academic and research institutes serve as primary grounds for basic research and discovery in epigenetics. These institutions strongly need advanced research tools such as next-generation sequencing (NGS), bioinformatics platforms, and epigenetic kits and reagents. The focus here is largely on understanding the mechanisms and implications of epigenetic changes rather than immediate commercial applications. Contract research organizations (CROs) operate as third-party service providers for various biotechnology, pharmaceutical, and medical device companies. They perform various services, from early-stage research to clinical trials and post-market support. In epigenetics, CROs need cutting-edge technologies that offer high-throughput capabilities and reliable validation services for drug discovery and development projects. CROs prefer robust, scalable solutions aligned with the pharmaceutical industry's stringent regulatory standards. Pharmaceutical and biotechnology companies are involved in developing and commercializing new drugs and treatments and an increasing number of these companies are being influenced by epigenetic insights. These companies require comprehensive epigenetic platforms that can streamline drug discovery, biomarker development, and therapeutic monitoring. The preference for pharma and biotech is for integrated solutions that deliver speed to market, efficacy, and safety.

Regional Insights

The epigenetics market in North America has exhibited substantial growth, primarily driven by the United States, attributed to heavy investments in research and development, the robust presence of pharmaceutical and biotechnology companies, and a high incidence rate of chronic diseases such as cancer. In South America, the adoption of epigenetics is in the nascent stage and has a potential for development due to the increasing prevalence of genetic disorders and cancers, and Brazil supports the development of epigenetics with an evolving healthcare sector and growing public awareness about advanced treatments. The APAC region is undergoing a rapid transition in the epigenetics sector due to emerging economies such as China, Japan, and India. China has witnessed a surge in patent filings, indicating strong governmental and private interest in epigenetics. The Japanese government encourages precision medicine, resulting in increased funding for epigenetic research programs. India's participation in epigenetic research is expanding, with an increasing number of collaborations and studies. Europe's epigenetics market is robust, led by countries such as Germany, the UK, and France. Extensive research activities, well-established healthcare systems, and growing investments from the private and public sectors propel the regional development. Additionally, active collaborations between key players and academic institutions support the development of advanced epigenetic therapies. The Middle East region is experiencing gradual progress in epigenetics due to the rising prevalence of conditions such as cancer and the expansion of healthcare infrastructure. The interest in personalized medicine is steadily gaining traction, influencing purchasing patterns. In Africa, the development of epigenetics is in the early stages, with limited research facilities. However, there is potential for expansion with increasing international collaboration in healthcare research.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Epigenetics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Epigenetics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Epigenetics Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Abnova Corporation, Active Motif, Inc., Agilent Technologies, Inc., AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., BioCat GmbH by AddLife AB, Bioneer Corporation, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Cambridge Epigenetix Ltd., Chroma Medicine, Inc., Creative Biogene, Creative Diagnostics, Cusabio Technology LLC, Diagenode S.A. by Hologic, Inc., Elysium Health, Inc., EpiCypher, Inc., Epigenic Therapeutics, EpiGentek Group Inc., Eurofins Scientific SE, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fios Genomics Ltd., FOXO Technologies Inc., GenomeScan, GenScript Biotech Corporation, Gilead Sciences, Inc., Illumina, Inc., Integrated DNA Technologies, Inc. by Danaher Corporation, Ipsen, Lonza Group Ltd., Merck KGaA, MorphoSys AG, New England Biolabs, Inc., Novogene Co, Ltd., Omega Therapeutics, Inc., Pacific Biosciences of California, Inc, PerkinElmer, Inc., Promega Corporation, ProteoGenix SAS, Qiagen N.V., Sound Agriculture Company, STORM Therapeutics LTD, Takara Holdings Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Watchmaker Genomics, Inc., Zenith Epigenetics Ltd., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Epigenetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Enzymes
      • DNA-Modifying Enzymes
      • Protein-Modifying Enzymes
    • Instruments & Accessories
    • Reagents & Kits
      • 5-hmC & 5-mC Analysis Kit
      • Antibodies
      • Bisulfite Conversion Kits
      • ChiP-seq Kits
      • Histones
      • Whole Genome Amplification Kits
    • Service
    • Software
  • Technique
    • Mass Spectrometry
    • Next-Generation Sequencing
    • Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
    • Sonication
  • Methods
    • DNA Methylation
    • Histone Modifications
  • Application
    • Cardiovascular Diseases
    • Developmental Biology
    • Immunology
    • Metabolic Diseases
    • Oncology
  • End User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Epigenetics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Epigenetics Market?

3. What are the technology trends and regulatory frameworks in the Epigenetics Market?

4. What is the market share of the leading vendors in the Epigenetics Market?

5. Which modes and strategic moves are suitable for entering the Epigenetics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant growth in the prevalence of chronic and genetic disorders worldwide
      • 5.1.1.2. Favorable governmental initiatives and investments in drug discovery and development
      • 5.1.1.3. Growing inclination toward personalized medicines
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of epigenetics technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development activities for the advancement of epigenetics
      • 5.1.3.2. Expanding the application of epigenetics in non-oncology fields
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness and limited application of epigenetics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing usage of reagents & kits for epigenetic research
    • 5.2.2. Technique: Expanding adoption of next-generation sequencing for genome-wide methylation profiling
    • 5.2.3. Methods: Rising utilization of DNA methylation for X-chromosome inactivation
    • 5.2.4. Application: Increasing application of epigenetic tools in oncology
    • 5.2.5. End-User: Growing need for epigenetic tools from academic & research institutes
  • 5.3. Market Trend Analysis
    • 5.3.1. Continuous epigenetics research for clinical and agricultural applications and technological advancements with a presence of major players in the Americas region
    • 5.3.2. Increasing research and development activities coupled with growing geriatric population in the APAC region
    • 5.3.3. Advanced healthcare infrastructure and strong epigenetics research activities associated with environment and agricultural applications in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Epigenetics Market, by Product

  • 6.1. Introduction
  • 6.2. Enzymes
  • 6.3. Instruments & Accessories
  • 6.4. Reagents & Kits
  • 6.5. Service
  • 6.6. Software

7. Epigenetics Market, by Technique

  • 7.1. Introduction
  • 7.2. Mass Spectrometry
  • 7.3. Next-Generation Sequencing
  • 7.4. Polymerase Chain Reaction & quantitative Polymerase Chain Reaction
  • 7.5. Sonication

8. Epigenetics Market, by Methods

  • 8.1. Introduction
  • 8.2. DNA Methylation
  • 8.3. Histone Modifications

9. Epigenetics Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Developmental Biology
  • 9.4. Immunology
  • 9.5. Metabolic Diseases
  • 9.6. Oncology

10. Epigenetics Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Epigenetics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Epigenetics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Epigenetics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Zenith and Cencora Partner to Expedite ZEN-3694 Programme
    • 14.3.2. FOXO, DataRobot Partner for AI-Based Epigenetic Biomarker Research
    • 14.3.3. Zymo Research and Opentrons Partner to Automate Novel Cell-Free DNA Isolation Chemistry
    • 14.3.4. MSU biochemist Receives USD 2.8 million NIH Grant For Epigenetic Research on Autism Spectrum Disorder
    • 14.3.5. Agilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer Research
    • 14.3.6. AstraZeneca Advances its Pipeline and Highlights Progress in Immuno-Oncology, ADCs, Cell Therapy and Epigenetics At AACR
    • 14.3.7. Biomodal Releases Genetics And Epigenetics Solution
    • 14.3.8. Chroma Medicine Raises Stakes in Epigenetic Editing
    • 14.3.9. Ipsen to Acquire Epizyme, Expanding its Portfolio in Oncology
    • 14.3.10. Zenith Epigenetics Announces Start of Several National Cancer Institute (NCI)-Sponsored Oncology Clinical Trials

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. EPIGENETICS MARKET RESEARCH PROCESS
  • FIGURE 2. EPIGENETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. EPIGENETICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EPIGENETICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. EPIGENETICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EPIGENETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EPIGENETICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL EPIGENETICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL EPIGENETICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL EPIGENETICS MARKET SIZE, BY DNA-MODIFYING ENZYMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL EPIGENETICS MARKET SIZE, BY PROTEIN-MODIFYING ENZYMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL EPIGENETICS MARKET SIZE, BY INSTRUMENTS & ACCESSORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL EPIGENETICS MARKET SIZE, BY 5-HMC & 5-MC ANALYSIS KIT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL EPIGENETICS MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL EPIGENETICS MARKET SIZE, BY BISULFITE CONVERSION KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL EPIGENETICS MARKET SIZE, BY CHIP-SEQ KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL EPIGENETICS MARKET SIZE, BY WHOLE GENOME AMPLIFICATION KITS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL EPIGENETICS MARKET SIZE, BY SERVICE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL EPIGENETICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL EPIGENETICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL EPIGENETICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL EPIGENETICS MARKET SIZE, BY POLYMERASE CHAIN REACTION & QUANTITATIVE POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL EPIGENETICS MARKET SIZE, BY SONICATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL EPIGENETICS MARKET SIZE, BY DNA METHYLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL EPIGENETICS MARKET SIZE, BY HISTONE MODIFICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL EPIGENETICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL EPIGENETICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL EPIGENETICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL EPIGENETICS MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL EPIGENETICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL EPIGENETICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL EPIGENETICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL EPIGENETICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 78. AMERICAS EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 79. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 80. AMERICAS EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 91. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 92. ARGENTINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 93. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 94. ARGENTINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 95. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 96. ARGENTINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 105. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. BRAZIL EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 108. BRAZIL EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 109. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 110. BRAZIL EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. CANADA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 122. CANADA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 123. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 124. CANADA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. CANADA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. MEXICO EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 136. MEXICO EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 137. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 138. MEXICO EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. MEXICO EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. UNITED STATES EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 150. UNITED STATES EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 151. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 152. UNITED STATES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 157. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. UNITED STATES EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 161. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 162. UNITED STATES EPIGENETICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 179. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. AUSTRALIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 182. AUSTRALIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 183. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 184. AUSTRALIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 186. AUSTRALIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 187. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 188. AUSTRALIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 189. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 190. AUSTRALIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 191. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. AUSTRALIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 194. CHINA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 195. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 196. CHINA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 197. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 198. CHINA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 199. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 200. CHINA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 201. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 202. CHINA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 203. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. CHINA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 206. CHINA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 207. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. INDIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 210. INDIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 211. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 212. INDIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 213. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 214. INDIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 215. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 216. INDIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 217. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. INDIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. INDIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. INDONESIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 224. INDONESIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 225. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 226. INDONESIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 227. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 228. INDONESIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 229. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 230. INDONESIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 231. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. INDONESIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. INDONESIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 236. JAPAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 237. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 238. JAPAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 239. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 240. JAPAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 241. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 242. JAPAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 243. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 244. JAPAN EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 245. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. JAPAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 248. JAPAN EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 249. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. MALAYSIA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 252. MALAYSIA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 253. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 254. MALAYSIA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 255. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 256. MALAYSIA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 257. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 258. MALAYSIA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 259. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. MALAYSIA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 262. MALAYSIA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 263. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. PHILIPPINES EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 266. PHILIPPINES EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 267. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 268. PHILIPPINES EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 270. PHILIPPINES EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 271. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 272. PHILIPPINES EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 273. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. PHILIPPINES EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. PHILIPPINES EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 278. SINGAPORE EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 279. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 280. SINGAPORE EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 281. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 282. SINGAPORE EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 283. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 284. SINGAPORE EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 285. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 286. SINGAPORE EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 287. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. SINGAPORE EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 290. SINGAPORE EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 291. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 292. SOUTH KOREA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 293. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 294. SOUTH KOREA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 295. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 296. SOUTH KOREA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 298. SOUTH KOREA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 299. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 300. SOUTH KOREA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 301. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 302. SOUTH KOREA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 303. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 304. SOUTH KOREA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 305. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 306. TAIWAN EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 307. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 308. TAIWAN EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 309. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 310. TAIWAN EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 311. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 312. TAIWAN EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 313. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 314. TAIWAN EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 315. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. TAIWAN EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 318. TAIWAN EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 319. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. THAILAND EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 322. THAILAND EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 323. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 324. THAILAND EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 325. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 326. THAILAND EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 327. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 328. THAILAND EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 329. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. THAILAND EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 332. THAILAND EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 333. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. VIETNAM EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 336. VIETNAM EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 337. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 338. VIETNAM EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 339. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 340. VIETNAM EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 341. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 342. VIETNAM EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 343. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 344. VIETNAM EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 345. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 346. VIETNAM EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 347. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 348. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 349. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 350. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 351. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 352. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 353. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 354. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 355. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 356. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 357. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 358. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 359. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 360. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 361. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 362. EUROPE, MIDDLE EAST & AFRICA EPIGENETICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 363. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 364. DENMARK EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 365. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 366. DENMARK EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)
  • TABLE 367. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2018-2023 (USD MILLION)
  • TABLE 368. DENMARK EPIGENETICS MARKET SIZE, BY REAGENTS & KITS, 2024-2030 (USD MILLION)
  • TABLE 369. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2018-2023 (USD MILLION)
  • TABLE 370. DENMARK EPIGENETICS MARKET SIZE, BY TECHNIQUE, 2024-2030 (USD MILLION)
  • TABLE 371. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2018-2023 (USD MILLION)
  • TABLE 372. DENMARK EPIGENETICS MARKET SIZE, BY METHODS, 2024-2030 (USD MILLION)
  • TABLE 373. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 374. DENMARK EPIGENETICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 375. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 376. DENMARK EPIGENETICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 377. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 378. EGYPT EPIGENETICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 379. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2018-2023 (USD MILLION)
  • TABLE 380. EGYPT EPIGENETICS MARKET SIZE, BY ENZYMES, 2024-2030 (USD MILLION)

TABL